Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
A series of experiments was performed to investigate the effects of corticotropin-releasing factor (CRF) on the amplitude of the acoustic startle response (ASR) in rats. Intracerebroventricular (ICV) administration of 1 microgram rat CRF significantly potentiated acoustic startle amplitude; these effects were reversed in a dose-dependent manner by pretreatment with the benzodiazepine chlordiazepoxide (CDP). Doses of CDP that antagonized CRF-potentiated ASR did not lower startle baseline or antagonize amphetamine- or strychnine-potentiated ASR. These results suggest that CRF has "anxiogenic" properties and may serve as a neuroendocrine modulator of stress-enhanced behaviors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“infusions of CRF into the lateral cerebral ventricle markedly increased the amplitude of the acoustic startle response in rats (CRF-enhanced startle).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Swerdlow et al, 1986
In the citing paper
“The benzodiazepine anxiolytic, chlordiazepozide, reduced this effect, but in control studies it did not reduce startle increases produced by the inhibitory glycine receptor antagonist strychnine”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Swerdlow et al, 1986
In the citing paper
“CRF-enhanced startle (Swerdlow et al, 1986)”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Swerdlow et al, 1986
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904 · cited 1×
“CRF is a 41 amino-acid polypeptide released within the median eminence from cells in the paraventricular nucleus of the hypothalamus, which stimulates the release of ACTH and/Lendorphin from the anterior pituitary (Rivier et al. 1981 ; Vale et al. 1981).”
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Self-citationA primary acoustic startle circuit: lesion and stimulation studies
Davis, M., Gendelman, D., Tischler, M., & Gendelman, P. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-06-00791.1982 · Cited by 969 · cited 1×
“acoustic startle is controlled by a well-characterized neural circuit (Davis et al. 1982), and thus permits an analysis of the neural substrates of anxiety (Mondlock and Davis 1985).”
Corticotropin releasing factor produces behavioural activation in rats
Sutton, R. E., Koob, G. F., Le Moal, M., Rivier, J., & Vale, W. (1982) · Nature · doi:10.1038/297331a0 · Cited by 754 · cited 3×
“1985), and are not produced by peripheral injections of CRF in doses greater by orders of magnitude (Sutton et al. 1982).”
InfluentialSelf-citationConditioned fear as revealed by magnitude of startle response to an auditory stimulus.
Brown, J. S., Kalish, H. I., & Farber, I. E. (1951) · Journal of Experimental Psychology · doi:10.1037/h0060166 · Cited by 637 · cited 1×
“In rats, the ASR has been shown to be sensitive to states of stress or fear, since ASR amplitude is enhanced by drugs (such as piperoxane and yohimbine) that have anxiogenic properties in humans (Davis and Astrachan 1981) and when the acoustic stimulus is presented during another stimulus (light, for example) that has…”
Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus
Valentino, R. J., Foote, S. L., & Aston-Jones, G. (1983) · Brain Research · doi:10.1016/0006-8993(83)90615-7 · Cited by 603 · cited 1×
“1983), and CRF has been shown to increase firing frequencies of cells within the locus coeruleus in vivo (Valentino et al. 1983), and to activate cells in hippocampal slice preparations (Aldenhoff et al.”
RIVIER, C., BROWNSTEIN, M., SPIESS, J., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-110-1-272 · Cited by 555
Self-citationHitchcock, J., & Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.1.11 · Cited by 541 · cited 1×
“1982), and thus permits an analysis of the neural substrates of anxiety (Mondlock and Davis 1985).”
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534 · cited 1×
“Koob stricted to the outer walls of the environment, together with decreased exploration and increased grooming (Britton et al. 1982).”
Self-citation
Research works printed but not linked: 2
- Britton T, Lyon M, Vale W, Koob G (1984) Stress-induced secretion of corticotropin releasing factor immunoreactivity in rat cerebrospinal fluid. Soc Neurosci Abstr 10:94
- Weiss S, Post R, Gold P, Chrousos G, Sullivan T, Walker D, Pert A (1984) CRF-induced aggressive behavior and seizures: facilitation of amygdala kindling. Soc Neurosci Abstr 10:178
Cited by
Items 101–200 of 301
Pomrenze, M. B., Giovanetti, S. M., Maiya, R., Gordon-Fennell, A., Kreeger, L. J., & Messing, R. O. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.083 · Cited by 101
“Because CRF is anxiogenic (Liang et al., 1992; Swerdlow et al., 1986) and activation of CeACRF neurons can produce anxiety-like behavior in mice (McCall et al.”
BackgroundBritton, K. T., Akwa, Y., Spina, M. G., & Koob, G. F. (2000) · Peptides · doi:10.1016/s0196-9781(99)00169-2 · Cited by 95
Self-citationExogenous cortisol exerts effects on the startle reflex independent of emotional modulation
Buchanan, T. W., Brechtel, A., Sollers, J. J., & Lovallo, W. R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00450-0 · Cited by 94
Neurohormonal perturbations in fibromyalgia
Crofford, L. J., Engleberg, N. C., & Demitrack, M. A. (1996) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(96)80022-7 · Cited by 103
Evidence for the role of corticotropin-releasing factor in major depressive disorder
Waters, R. P., Rivalan, M., Bangasser, D. A., Deussing, J. M., Ising, M., Wood, S. K., Holsboer, F., & Summers, C. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.011 · Cited by 93
“In agreement with the established positive relationships of CRF with multiple modes of stress related behavior (Berridge and Dunn, 1986; Swerdlow et al., 1986; Britton et al., 1982, 1986a; Koob et al., 1993; Sutton et al., 1982), CRF antagonists are capable of attenuating or reversing the effects of various stressors,…”
BackgroundGeneralized anxiety disorder: neurobiological and pharmacotherapeutic perspectives
Connor, K. M., & Davidson, J. R. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00285-6 · Cited by 94
Matsuzaki, I., Takamatsu, Y., & Moroji, T. (1989) · Neuropeptides · doi:10.1016/0143-4179(89)90085-1 · Cited by 92
Fossey, M. D., Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Bissette, G., & Nemeroff, C. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00197-2 · Cited by 90
Ryan, P. J., Büchler, E., Shabanpoor, F., Hossain, M. A., Wade, J. D., Lawrence, A. J., & Gundlach, A. L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.034 · Cited by 98
“19 In addition, while central administration of CRF is anxiogenic in several animal behavioural tests, including the unfamiliar open field [70], the elevated plus maze [71] and the acoustic startle response test [72], several findings suggest that this effect is independent of the HPA axis [73].”
BackgroundLee, Y., Fitz, S., Johnson, P. L., & Shekhar, A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301674 · Cited by 89
Towards new approaches to disorders of fear and anxiety
Dias, B. G., Banerjee, S. B., Goodman, J. V., & Ressler, K. J. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.013 · Cited by 106
“Seeing that the triggering of anxious and fearful behavior are stimuli that are perceived as stressful and threatening, it should come as no surprise that Corticotropin Releasing Factor (CRF) at the apex of the Hypothalamic-Pituitary-Adrenal axis plays a pivotal role in the manifestation of these states [24,25].”
BackgroundIs Corticotropin‐Releasing Factor a Mediator of Stress Responses?a
Dunn, A. J., & Berridge, C. W. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb48360.x · Cited by 87
Toufexis, D. J., Davis, C., Hammond, A., & Davis, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1386-04.2004 · Cited by 86
“ICV injection of CRF also increases the amplitude of the acoustic startle reflex (Swerdlow et al., 1986; Liang et al., 1992).”
BackgroundAcute pharmacological modulation of mGluR8 reduces measures of anxiety
Duvoisin, R. M., Pfankuch, T., Wilson, J. M., Grabell, J., Chhajlani, V., Brown, D. G., Johnson, E., & Raber, J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.04.006 · Cited by 78
Chappell, P., Leckman, J., Goodman, W., Bissette, G., Pauls, D., Anderson, G., Riddle, M., Scahill, L., McDougle, C., & Cohen, D. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00221-9 · Cited by 85
Substance use modulates stress reactivity: Behavioral and physiological outcomes
Fosnocht, A. Q., & Briand, L. A. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.02.024 · Cited by 87
“As CRF administration enhances stress related behaviors such as acoustic startle, conditioned fear and stress-induced freezing behavior [75, 76], the increase in activation of stress systems following chronic drug use provides a mechanism by which addiction leads to a dysregulation of stress responding in addicts.”
BackgroundDirks, A., Groenink, L., Schipholt, M. L., van der Gugten, J., Hijzen, T. H., Geyer, M. A., & Olivier, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01323-3 · Cited by 90
Self-citationElevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety
Harris, A. C., & Gewirtz, J. C. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1573-0 · Cited by 90
“Swerdlow et al. 1986; Walker and Davis 2002).”
BackgroundInfluentialICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity
Sherman, J. E., & Kalin, N. H. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90103-7 · Cited by 84
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice
Nielsen, D. M., Carey, G. J., & Gold, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.091 · Cited by 87
“, 2002; Owens and Nemeroff, 1991) and anxiety (Britton et al., 1982; Dunn and Berridge, 1990; Dunn and File, 1987; Koob et al., 1994; Momose et al., 1999; Sutton et al., 1982; Swerdlow et al., 1986), whereas central administration of CRF receptor antagonists (Berridge and Dunn, 1987; Heinrichs et al.”
BackgroundCarli, M., Prontera, C., & SAMANIN, R. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90081-6 · Cited by 82
The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome
Crofford, L. J. (1998) · Zeitschrift für Rheumatologie · doi:10.1007/s003930050239 · Cited by 82
Anxiolytic-like effects of glycine receptor ligands in the rat potentiated startle test
Anthony, E. W., & Nevins, M. E. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90397-z · Cited by 86
Corticotronpin-releasing hormone inhibits maternal behavior and induces pup-killing
Pedersen, C. A., Caldwell, J. D., McGuire, M., & Evans, D. L. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90278-j · Cited by 78
Neuroendocrine correlates of chronic fatigue syndrome: A brief review
Demitrack, M. A. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00059-3 · Cited by 84
Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat
Hefner, K. R., & Curtin, J. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111416691 · Cited by 74
“Bright light, temporally uncertain shock, and infusions of the anxiogenic peptide corticotropin-releasing factor (CRF) potentiate startle response in rats (Liang et al., 1992; Swerdlow et al., 1986; Walker and Davis, 1997).”
Holsboer, F. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb08556.x · Cited by 73
Hogle, J. M., Kaye, J. T., & Curtin, J. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.003 · Cited by 73
Demitrack, M. A., Gold, P. W., Dale, J. K., Krahn, D. D., Kling, M. A., & Straus, S. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90187-5 · Cited by 72
The predator odor avoidance model of post-traumatic stress disorder in rats
Albrechet‐Souza, L., & Gilpin, N. W. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000460 · Cited by 73
“In fact, exogenously administered CRF produces anxiogenic effects in rodents (Swerdlow et al., 1986; Arborelius et al., 1999), and alcohol-dependent rats exhibit increases in anxietylike behavior and escalated alcohol self-administration Predator odor avoidance model of PTSD Albrechet-Souza and Gilpin 109”
The effects of ICV-CRH on novelty-induced behavior
Sherman, J. E. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90599-5 · Cited by 69
Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain
Goeders, N. E., Bienvenu, O. J., & Souza, E. B. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90794-c · Cited by 71
CHEN, M., Chiu, T. H., & Lee, E. H. Y. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90050-h · Cited by 68
Lehnert, H., Schulz, C., & Dieterich, K. (1998) · Neurochemical Research · doi:10.1023/a:1020751817723 · Cited by 66
“Fear is also found to be enhanced in an acoustic startle and a social interaction test (159,160).”
BackgroundSwiergiel, A. H., ZHOU, Y., & Dunn, A. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.06.006 · Cited by 67
Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans
Grillon, C., Pine, D. S., Baas, J. M. P., Lawley, M., Ellis, V., & Charney, D. S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0124-2 · Cited by 69
“CRH also increased markedly the magnitude of the startle reflex when given intraventricularly (Liang et al. 1992; Swerdlow et al. 1986).”
BackgroundChorvat, R. J., Bakthavatchalam, R., Beck, J. P., Gilligan, P. J., Wilde, R. G., Cocuzza, A. J., Hobbs, F. W., Cheeseman, R. S., Curry, M. A., Rescinito, J. P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980224g · Cited by 66
Imaki, T., Xiao-Quan, W., Shibasaki, T., Harada, S., Chikada, N., Takahashi, C., Naruse, M., & Demura, H. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00086-8 · Cited by 68
CHRONIC FATIGUE SYNDROME AND FIBROMYALGIA
Demitrack, M. A. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70031-9 · Cited by 65
Kalin, N. H., Shelton, S. E., Barksdale, C. M., & Brownfield, M. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)90894-8 · Cited by 62
Fendt, M., Koch, M., & Schnitzler, H. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01400.x · Cited by 61
Lee, E. H. Y., Hung, H.-C., Lu, K., Chen, W. H., & Chen, H. Y. (1992) · Peptides · doi:10.1016/0196-9781(92)90051-4 · Cited by 63
Behavioral activation by CRF: Evidence for the involvement of the ventral forebrain
Tazi, A., Swerdlow, N. R., Moal, M. L., Rivier, J., Vale, W., & Koob, G. F. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90554-6 · Cited by 61
Self-citationAlcohol stress response dampening during imminent versus distal, uncertain threat.
Hefner, K. R., Moberg, C. A., Hachiya, L. Y., & Curtin, J. J. (2013) · Journal of Abnormal Psychology · doi:10.1037/a0033407 · Cited by 55
Kalin, N. H., & Takahashi, L. K. (1990) · Brain Research · doi:10.1016/0006-8993(90)90311-x · Cited by 59
Baiamonte, B. A., Valenza, M., Roltsch, E. A., Whitaker, A. M., Baynes, B. B., Sabino, V., & Gilpin, N. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.025 · Cited by 58
The center of the emotional universe: Alcohol, stress, and CRF1 amygdala circuitry
Agoglia, A. E., & Herman, M. A. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.03.009 · Cited by 61
Servatius, R. J., Beck, K. D., Moldow, R. L., Salameh, G., Tumminello, T., & Short, K. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.015 · Cited by 62
Hougaard, K. S., Andersen, M. B., Kjær, S. L., Hansen, Å. M., Werge, T. M., & Lund, S. P. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.06.014 · Cited by 57
Development of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date
Valdez, G. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620110-00002 · Cited by 58
de Jongh, R., Groenink, L., van der Gugten, J., & Olivier, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00468-2 · Cited by 54
Willick, M. L., & Kokkinidis, L. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.5.929 · Cited by 53
Weathington, J. M., Hamki, A., & Cooke, B. M. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23475 · Cited by 53
“CRF1 agonists promote anxiety-like behavior such as fearpotentiated startle (Swerdlow et al., 1986), while CRF1 antagonists reduce anxiety and depression-like symptoms (Takahashi, 2001).”
BackgroundDo panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology?
Kellner, M. B., & Yehuda, R. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00012-8 · Cited by 59
Behavioral Effects of Corticotropin-Releasing Factor
Baldwin, H. A., Britton, K. T., & Koob, G. F. (1990) · Current topics in neuroendocrinology · doi:10.1007/978-3-642-75837-9_1 · Cited by 53
Self-citationHand, G. A., Hewitt, C. B., Fulk, L. J., Stock, H. S., Carson, J. A., Davis, J. M., & Wilson, M. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02972-4 · Cited by 57
Lee, Y., & Davis, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06424.1997 · Cited by 51
Toufexis, D. J., Davis, C., Hammond, A. S., & Davis, M. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0127-05.2005 · Cited by 54
“Swerdlow et al. (1986) showed that CRF infused into the lateral ventricle of rats increased the magnitude of the acoustic startle reflex for at least 2 h. Studies by Liang et al. (1992) and Lee and Davis (1997a,b) characterized the dose–response of CRF on acoustic startle and demonstrated that…”
MethodCRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues
Risbrough, V. B., Geyer, M. A., Hauger, R. L., Coste, S., Stenzel-Poore, M., Wurst, W., & Holsboer, F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.205 · Cited by 49
“In rodents, exogenous CRF administration increases startle, an effect that can be attenuated by anxiolytic treatment (Swerdlow et al, 1986, 1989).”
BackgroundSelf-citationLee, E. H. Y., & Tsai, M. J. (1989) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(89)91052-2 · Cited by 57
Kagamiishi, Y., Yamamoto, T., & Watanabe, S. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.021 · Cited by 53
Harris, A. C., Hanes, S. L., & Gewirtz, J. C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1889-4 · Cited by 49
“1997) or intracerebroventricular administration of the anxiogenic neuropeptide corticotrophin-releasing factor (Swerdlow et al. 1986; Risbrough et al. 2003).”
Plasminogen regulates pro‐opiomelanocortin processing
Wang, N., Zhang, L., Miles, L. A., & Hoover-Plow, J. L. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00694.x · Cited by 47
Brush, F. R. (2003) · Behavior Genetics · doi:10.1023/a:1026135231594 · Cited by 46
“These have been observed in experiments using CER suppression (Cole and Koob, 1988), the Geller-Seifert conflict test (Britton et al., 1985), tests using social interactions to assess anxiety (Dunn and File, 1987), and enhancement of the spinal acoustic startle reflex ( Swerdlow et al., 1986 ).”
MethodBritton, K. T., McLeod, S., Koob, G. F., & Hauger, R. L. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90117-x · Cited by 46
Self-citationvon Bardeleben, U., & Holsboer, F. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90079-6 · Cited by 45
Fox, J. H., Hassell, J. E., Siebler, P. H., Arnold, M. R., Lamb, A. K., Smith, D. G., Day, H. E. W., Smith, T. M., Simmerman, E. M., Outzen, A. A., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.014 · Cited by 44
Walker, L. C., Cornish, L. C., Lawrence, A. J., & Campbell, E. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.037 · Cited by 52
Enhancement of the acoustic startle reflex by an alarm pheromone in male rats
Inagaki, H., Kiyokawa, Y., Kikusui, T., Takeuchi, Y., & Mori, Y. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.021 · Cited by 47
Roltsch, E. A., Baynes, B. B., Mayeux, J. P., Whitaker, A. M., Baiamonte, B. A., & Gilpin, N. W. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.005 · Cited by 43
“Exogenously administered CRF increases anxiety-like behaviour in rodents (Arborelius et al., 1999; Swerdlow et al., 1986a).”
BackgroundPhysiological Roles of Corticotropin-Releasing Hormone Receptor Type 2.
Hashimoto, K., Makino, S., Asaba, K., & Nishiyama, M. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.1 · Cited by 47
Sternberg, E. M., Wilder, R. L., Gold, P. W., & Chrousos, G. P. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb40488.x · Cited by 45
Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors
Sink, K. S., Chung, A., Ressler, K. J., Davis, M., & Walker, D. L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.024 · Cited by 43
“perisomatic baskets around BNST cells that express corticotropin releasing factor (CRF) [7], another peptide well known for its involvement in stress and anxiety [8, 9].”
BackgroundRasmussen, D. D., Crites, N. J., & Burke, B. L. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.11.010 · Cited by 39
“Intracerebroventricular (icv) administration of corticotropin-releasing factor (CRF) is anxiogenic and potentiates the acoustic startle (Swerdlow et al., 1986), and icv administration of CRF receptor antagonist can suppress both light-enhanced startle (de Jongh et al.”
BackgroundInfluentialCostine, B. A., Oberlander, J. G., Davis, M. C., Penatti, C. A. A., Porter, D. M., Leaton, R. N., & Henderson, L. P. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.04.015 · Cited by 41
“CRF, acting primarily through CRFR1, augments the ASR, but not FPS, and the BnST is the critical site for CRF-dependent ASR enhancement (Swerdlow et al., 1986; 1989; Liang et al., 1992; Risbrough et al., 2003, 2004; Risbrough and Geyer, 2005; Walker et al., 2009a,b).”
BackgroundPark, P. E., Vendruscolo, L. F., Schlosburg, J. E., Edwards, S., Schulteis, G., & Koob, G. F. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000308 · Cited by 37
“Previous studies indicated that the startle response is elevated by i.c.v. CRF administration and anxiolytics, such as chlordiazepoxide, block this effect (Swerdlow et al., 1986).”
BackgroundInfluentialSelf-citationSingh, V. K., HAOPHAN, T., Corley, K., & Boadle‐Biber, M. C. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90129-f · Cited by 38
Miller, M. W., McKinney, A. E., Kanter, F. S., Korte, K. J., & Lovallo, W. R. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.12.009 · Cited by 37
“…in rats, intracerebroventricular infusion of CRH produces a pronounced, dose-dependent enhancement of the startle response while this effect is blocked by pre-treatment with a CRH receptor antagonist (Swerdlow et al., 1989, 1986; Liang et al., 1992; Lee et al., 1994; Declan et al., 1998).”
Diurnal variation of the startle reflex in relation to HPA‐axis activity in humans
Miller, M. W., & Gronfier, C. (2006) · Psychophysiology · doi:10.1111/j.1469-8986.2006.00400.x · Cited by 45
“Under normal conditions, cortisol levels show a robust diurnal rhythm that is in phase opposition with CRH, a well-established modulator of startle amplitude (Liang et al., 1992; Swerdlow et al., 1986, 1989).”
BackgroundEhlers, C. L., & Chaplin, R. I. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90176-5 · Cited by 37
Neuropeptide systems and new treatments for nicotine addiction
Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36
“Some of the first studies with CRF showed that it increases anxiety-like behavior, and more recent studies showed that it contributes to anxiety-like behavior after cessation of nicotine administration (Cohen et al. 2015; Dunn and File 1987; Swerdlow et al. 1986).”
Nair, H. P., Gutman, A. R., Davis, M., & Young, L. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2524-05.2005 · Cited by 36
“Because other anxiogenic manipulations such as intracerebroventricular CRF infusions (Swerdlow et al., 1986; Liang et al., 1992; Lee and Davis, 1997) or a bright light (Walker and Davis, 1997) increase startle, we presume that the IPS effect observed here also reflects increased anxiety, albeit…”
BackgroundYokoyama, F., Yamauchi, M., Oyama, M., Okuma, K., Onozawa, K., Nagayama, T., Shinei, R., Ishikawa, M., Sato, Y., & Kakui, N. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1528-1 · Cited by 38
“Anxiety behavior can be triggered by central injection of CRF ( Swerdlow et al. 1986 ), whereas CRF1 receptor antagonists exhibit anxiolytic-like activities in the isolation-induced vocalization test (Hodgson et al. 2007), the resident–intruder test (Farrokhi et al. 2004), and the conditioned fear stress test (Hikichi…”
BackgroundImaki, J., Imaki, T., Vale, W., & Sawchenko, P. E. (1991) · Brain Research · doi:10.1016/0006-8993(91)90571-c · Cited by 35
Self-citationStress and corticotropin-releasing factor potentiate center region activity of mice in an open field
Lee, E. H. Y., Tang, Y. P., & Chai, C. Y. (1987) · Psychopharmacology · doi:10.1007/bf00187250 · Cited by 35
“The results of the present study are consistent with evidence that low to moderate doses of CRF produce behavioral activation, while high dose of CRF produces the opposite effect (Swerdlow et al. 1986).”
BackgroundResultInfluentialLee, E. H. Y., & Lin, W. R. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90530-o · Cited by 35
Imaki, T., & Vale, W. (1993) · Brain Research · doi:10.1016/0006-8993(93)91431-q · Cited by 34
Self-citationPeripherally administered CRH suppresses the vocalizations of isolated guinea pig pups
Hennessy, M. B., Becker, L. A., & O'Neil, D. R. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90492-7 · Cited by 33
Aging Effects on the Startle Response and Startle Plasticity in Fischer F344 Rats
Varty, G. B., Hauger, R. L., & Geyer, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00053-0 · Cited by 38
Self-citationOberlander, J. G., & Henderson, L. P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.334 · Cited by 33
“CRF, acting primarily through CRF-R1, augments the ASR, and the BnST is the critical site for CRFdependent enhancement of the ASR (Swerdlow et al, 1986, 1989; Liang et al, 1992; Risbrough et al, 2003, 2004; Risbrough and Geyer, 2005; Walker et al, 2009a, b).”
BackgroundSutherland, J. E., & Conti, L. H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.022 · Cited by 31
“…increases startle amplitude in WKY and Sprague-Dawley rats (Conti et al., 2002; Jones et al., 1998; Liang et al., 1992; Schulz et al., 1996; Swerdlow et al., 1986; Walker et al., 2009), and this effect is blocked by pretreatment with a selective CRF1 receptor antagonist (Schulz et al.,…”
BackgroundGresack, J. E., & Risbrough, V. B. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001409 · Cited by 32
“…CRF effects on startle reactivity is dissociable from CRF-mediated changes in PPI. oCRF robustly increased startle in all experiments, consistent with earlier rodent findings wherein r/h-CRF increased startle magnitude (Liang et al. 1992 ; Risbrough et al. 2003, 2004 ; Swerdlow et al. 1986, 1989).”
Kaye, J. T., Bradford, D. E., Magruder, K. P., & Curtin, J. J. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.353 · Cited by 31
“Direct injections of CRF or NE agonists, particularly into the extended amygdala, also increase anxiety-like behavior at baseline and during drug deprivation (George et al., 2007; Liang et al., 1992; Park et al., 2013; Swerdlow et al., 1986).”
BackgroundAssociation and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder
Hodges, L. M., Weissman, M. M., Haghighi, F. G., Costa, R., Bravo, O., Evgrafov, O. V., Knowles, J. A., Fyer, A. J., & Hamilton, S. P. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30773 · Cited by 32
“Exogenous administration [Swerdlow et al., 1986; Butler et al., 1990; Sahuque et al., 2006; Yang et al., 2006] or overexpression”
BackgroundSkelton, K. H., Gutman, D. A., Thrivikraman, K. V., Nemeroff, C. B., & Owens, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0713-3 · Cited by 28
“…Kalogeras et al. 1990; Rohrer et al. 1994; Cowley et al. 1995), attenuation of stressinduced CRF transcription and release (Imaki et al. 1995; Pich et al. 1995), and reduction in the anxiogenic effects of centrally administered CRF (Britton et al. 1985; Swerdlow et al. 1986; Dunn and File 1987).”
BackgroundLee, E. H. Y., & Sung, Y. J. (1989) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(89)90412-3 · Cited by 28
Hoover-Plow, J. L., Skomorovska-Prokvolit, O., & Welsh, S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02191-6 · Cited by 27
Chronic fatigue syndrome: The need for an integrative approach
Demitrack, M. A., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90231-a · Cited by 29
Role of the PACAP system of the extended amygdala in the acoustic startle response in rats
Seiglie, M. P., Huang, L., Cottone, P., & Sabino, V. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107761 · Cited by 27
“Intracerebroventricular CRF infusions are able to potentiate startle responses (CRF-enhanced startle) [99], and excitotoxic lesions of the BNST, but not CeA, completely block this enhanced startle [100].”
BackgroundKöfler, M., Müller, J. W., & Valls‐Solé, J. (2006) · Supplements to Clinical neurophysiology · doi:10.1016/s1567-424x(09)70072-8 · Cited by 26
Metadata
- Authors
- Swerdlow, N. R., Geyer, M. A., Vale, W. W., & Koob, G. F.
- Affiliations
- University of California San Diego (US)
- Salk Institute for Biological Studies (US)
- Scripps Clinic (US)
- Venue
- Psychopharmacology
- Published
- 1986
- Volume
- 88
- Issue
- 2
- Pages
- 147-152
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2010001782
- Cited by
- 299
- References
- 34
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 4
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2p01am026741-06)
- National Institute of General Medical Sciences (GM 07198-10)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- corticotropin-releasing factor, acoustic startle response, chlordiazepoxide, benzodiazepines, anxiogenic effects, stress, neuroendocrine regulation, intracerebroventricular administration
- MeSH terms
- Acoustic Stimulation, Animals, Anxiety, Chlordiazepoxide, Corticotropin-Releasing Hormone, Dextroamphetamine, Drug Interactions, Male, Rats, Inbred Strains, Reflex, Startle, Strychnine, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.